Help improve access to a new Parkinson’s medication

04_Neupro-article-imageDo you use the Parkinson’s treatment NEUPRO®? If so, we would like to hear from you.

Parkinson Society Canada is looking to make a stronger case to the Canadian Agency for Drugs and Technologies in Health (CADTH) on the need for Canadians affected by Parkinson’s to have access to the new Parkinson’s treatment NEUPRO®.

We will be interviewing members of our community about their experiences with this treatment. Whether you are directly affected, or you are a caregiver of someone with Parkinson’s and taking NEUPRO®, your input is crucial in our efforts to improve access to this treatment.

The NEUPRO® patch is a dopamine agonist used for the treatment of Parkinson’s disease and restless legs syndrome. It works by delivering a steady stream of Parkinson’s medication over a 24-hour period through the surface of your skin from the once-a-day applied patch, effectively diminishing the need for repeated dosing throughout the day.

If you would like to share your experiences on NEUPRO®, please contact us at advocacy@parkinson.ca and provide your name, email address and a phone number where you can be reached. We will then contact you to arrange a time to speak with you at your convenience. These confidential discussions should take about 10 to 20 minutes.

Parkinson Society Canada thanks all members of our community for contributing their feedback on the use of NEUPRO®. The results of our submission to CADTH will be shared with you in the near future.

Privacy Policy: To ensure personal privacy and confidentiality, individual responses will not be identifiable. It is important to note that selected quotations may be used without reference to an individual’s name.

1 Response to “Help improve access to a new Parkinson’s medication”


  1. 1 Russell Jazzar March 8, 2015 at 11:58 am

    How does one access this treatment?


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s




Charitable registration number 10809 1786 RR0001
All material related to Parkinson's disease contained in Parkinson Post is solely for the information of the reader. It should not be used for treatment purposes. Specific articles reflect the opinion of the writer and are not necessarily the opinion of PSC.

%d bloggers like this: